Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01516281 · ClinicalTrials.gov registry record
Imaging Biomarkers of Delayed Sequelae in Trauma Brain Injury
A clinical trial, sponsored by Endeavor Health.
- Completed
- Registry status
- 67
- Enrollment target
NCT01516281 is a clinical trial that has completed, run by Endeavor Health. The registered enrollment target is 67 participants.
The verdict
NCT01516281 has completed, sponsored by Endeavor Health.
- COMPLETED
- Registry status
- 67 participants
- Enrollment target
Study Summary
The purpose of this study is to learn if a new brain imaging technology called DaTscan can detect subtle changes in the brain that are similar to those seen in early Parkinson's disease (PD). The results of this study may provide more information about a possible association between mild to moderate traumatic brain injury (mTBI) and PD. The objectives of this study are to define and describe a group of approximately 7,122 mTBI subjects and 7,122 subjects without mTBI (mTBI-) seen in the Emergency Rooms of NorthShore University HealthSystem during the years 2006-2011, and to select from willing eligible subjects a random sample of 100 mTBI subjects and 100 mTBI- subjects (of the same age and gender) to undergo written informed consent, neurological examinations, blood drawing for DNA extraction and storage, and DaTscan brain imaging. The investigators will compare the findings from persons who experienced mTBI (cases) to persons without a history of brain injury (mTBI- or "controls").
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 67 participants |
| Start Date | 2012-03 |
| Est. Completion | 2015-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01516281
The ClinicalTrials.gov registry entry for NCT01516281 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 67 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Endeavor Health, which has 94 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT01516281 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01516281 about?
NCT01516281 is a clinical study titled "Imaging Biomarkers of Delayed Sequelae in Trauma Brain Injury". The purpose of this study is to learn if a new brain imaging technology called DaTscan can detect subtle changes in the brain that are similar to those seen in early Parkinson's disease (PD). The results of this study may provide more information about a possible association between mild to moderate...
What is the current status of trial NCT01516281?
This trial is currently completed. The enrollment target is 67 participants. The study started on 2012-03. Estimated completion is 2015-12.
Who is sponsoring clinical trial NCT01516281?
This trial is sponsored by Endeavor Health, which has 94 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.